Stay updated with the latest eli-lilly news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on eli-lilly topics.
(Reuters) -Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said. "We are making significant investments to increase manufactu ...Read More >
AstraZeneca is benefiting from surging demand for cancer treatments like Imfinzi and Calquence, and has a robust pipeline expected to deliver two dozen new products by 2030. Leading vaccine makers like Eli Lilly (NYSE:LLY), Pfizer (NYSE:PFE), and AstraZeneca NASDAQ:AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic, but now there is reason to expect renewed interest. As investors look ahead to the second Trump administration, the incoming president's nomination of ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.